Cargando…

MPC-04 MOLECULAR FEATURES AND CLINICAL OUTCOMES OF ELDERLY GLIOBLASTOMA PATIENTS: ANALYSES OF KANSAI NETWORK AND TCGA COHORTS

INTRODUCTION: Aging is a negative prognostic factor in glioblastoma (GB) and the genetic background in clinical outcome of elderly GB could exist. This study investigates the difference of elderly patients from younger ones regarding molecular characteristics as well as clinical outcomes in IDH-wild...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukai, Junya, Arita, Hideyuki, Umehara, Toru, Yoshioka, Ema, Shofuda, Tomoko, Kodama, Yoshinori, Kinoshita, Manabu, Okita, Yoshiko, Nonaka, Masahiro, Uda, Takehiro, Sakamoto, Daisuke, Mori, Kanji, Kanemura, Yonehiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213341/ http://dx.doi.org/10.1093/noajnl/vdz039.101

Ejemplares similares

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors
por: Sasaki, Takahiro, et al.
Publicado: (2018)

NI-13 The effectiveness and limitation of survival prediction in primary glioblastoma using machine learning-based texture analysis
por: Umehara, Toru, et al.
Publicado: (2020)

NI-13 PREDICTION OF PROGNOSIS IN NEWLY DIAGNOSED GLIOBLASTOMA USING MACHINE LEARNING-BASED TEXTURE ANALYSIS OF PREOPERATIVE MRI
por: Umehara, Toru, et al.
Publicado: (2019)

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts
por: Umehara, Toru, et al.
Publicado: (2019)

TB-08 PATIENT DERIVED XENOGRAFT’S BIOBANK FROM KANSAI MOLECULAR DIAGNOSIS NETWORK FOR CENTRAL NERVOUS SYSTEM TUMORS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

NI-02 THE ASSOCIATION BETWEEN (11)C-METHIONINE UPTAKE, IDH GENE MUTATION, AND MGMT PROMOTER METHYLATION IN PATIENTS WITH GRADE II AND III GLIOMAS
por: Okita, Yoshiko, et al.
Publicado: (2019)

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma
por: Sasaki, Takahiro, et al.
Publicado: (2019)

Ipsilateral hemiparesis caused by putaminal hemorrhage in a patient with horizontal gaze palsy with progressive scoliosis: a case report
por: Yamada, Shuhei, et al.
Publicado: (2015)

MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
por: Satomi, Kaishi, et al.
Publicado: (2021)

TB-8 Genetic and molecular properties of long-term proliferating tumorsphere -forming glioma derived cells
por: Kijima, Noriyuki, et al.
Publicado: (2021)

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas
por: Arita, Hideyuki, et al.
Publicado: (2018)

ACT-10 TREATMENT FOR GLIOBLASTOMA RECURRED AFTER CONCOMITANT CHEMORADIATION THERAPY WITH TEMOZOLOMIDE AND THEIR PROGNOSIS
por: Mori, Kanji, et al.
Publicado: (2019)

Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report
por: OKITA, YOSHIKO, et al.
Publicado: (2015)

MPC-01 PROGNOSTIC ROLE OF TERT PROMOTER IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA
por: Arita, Hideyuki, et al.
Publicado: (2019)

Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network
por: Fukuma, Ryohei, et al.
Publicado: (2019)

Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion
por: Achiha, Takamune, et al.
Publicado: (2020)

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
por: Makino, Yasuhide, et al.
Publicado: (2021)

MPC-02 REVIEW OF MEDULLOBLASTOMA FOR THE ASSESSMENT OF CONSENSUS IN PATHOLOGICAL DIAGNOSIS USING JPMNG CASES
por: Sasaki, Atsushi, et al.
Publicado: (2019)

MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation
por: Fukuoka, Kohei, et al.
Publicado: (2021)

Kansai Japanese : the language of Ōsaka, Kyōto, and Western Japan
por: Tse, Peter
Publicado: (1994)

Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases
por: TAKEUCHI, Hayato, et al.
Publicado: (2022)

LGG-38. GENETIC ANALYSIS OF NEUROEPITHELIAL TUMORS IN THE PEDIATRIC AND ADOLESCENT AND YOUNG ADULT AGE IN A SINGLE INSTITUTE
por: Makino, Yasuhide, et al.
Publicado: (2020)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among Facilities
por: Takahashi, Satoshi, et al.
Publicado: (2021)

MPC-04 Utility of comprehensive cancer genome analysis for brain tumors
por: Miwa, Kazuhiro, et al.
Publicado: (2020)

Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with (18)F-fluciclovine: A Comparative Study with L-methyl-(11)C-methionine PET Imaging
por: Tsuyuguchi, Naohiro, et al.
Publicado: (2017)

Small-scale screening of anticancer drugs acting specifically on neural stem/progenitor cells derived from human-induced pluripotent stem cells using a time-course cytotoxicity test
por: Fukusumi, Hayato, et al.
Publicado: (2018)

Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
por: Makino, Yasuhide, et al.
Publicado: (2021)

Isolation and pathogenicity of the mammalian orthoreovirus MPC/04 from masked civet cats
por: Li, Zhijie, et al.
Publicado: (2015)

MBRS-38. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF 236 MEDULLOBLASTOMAS IN JAPAN
por: Kanemura, Yonehiro, et al.
Publicado: (2020)

Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas
por: Kinoshita, Manabu, et al.
Publicado: (2016)

COT-1 Clinical Questions and Answers about Glioma-Related Epilepsy (GRE): Real-world data in Wakayama Medical University Hospital
por: Fukai, Junya, et al.
Publicado: (2021)

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
por: Nakaya, Aya, et al.
Publicado: (2018)

Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
por: Harita, Nobuko, et al.
Publicado: (2009)

TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma
por: Kikuchi, Zensho, et al.
Publicado: (2020)

Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins
por: Fukusumi, Hayato, et al.
Publicado: (2016)

Design of Electron Beam Injection System for Laser Acceleration Experiments at JAERI-Kansai
por: Kando, M, et al.
Publicado: (1999)

Relationship Between Alcohol Drinking Pattern and Risk of Proteinuria: The Kansai Healthcare Study
Publicado: (2016)

The Association Between Metabolically Healthy Obesity and the Risk of Proteinuria: The Kansai Healthcare Study
por: Uehara, Shinichiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r7pf4lsrvrpeaeduqmrnen0pln